Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Morley

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
QJM : Monthly Journal of the Association of Physicians|July 1, 1997
Keratin and the skin: past, present and futureS M Morley
Hospital Medicine (London, England : 1998)|November 25, 2000
Hydroxyurea-induced leg ulcersJ Murphy, S M Morley
Clinical and Experimental Dermatology|January 1, 1985
Epidermal thickness in systemic sclerosis and morphoeaS M Morley, P M Gaylarde, I Sarkany
Journal of the European Academy of Dermatology and Venereology : JEADV|May 11, 2006
Calciphylaxis--a topical overviewG Arseculeratne, A T Evans, S M Morley
The Journal of Pathology|July 1, 1983
Membrane-bound structures at the interface between tumour and dermis in basal cell carcinoma. An ultrastructural studyS M Morley, A Rennison, R F Macadam
Journal of Clinical Pathology|August 1, 1987
Unresponsiveness to skin testing with bacterial antigens in patients with haemophilia A not apparently infected with human immunodeficiency virus (HIV)R A Sharp, S M Morley, J S Beck, et al.
Tubercle|March 1, 1987
Occupational exposure to Mycobacterium tuberculosis and cytology of response to skin testing with 'New Tuberculin'S M Morley, J S Beck, R A Brown, et al.
Clinical and Experimental Immunology|September 1, 1987
The method of preparation of an antigen may influence the cellular reaction to it in skin tests for delayed hypersensitivity: comparison between responses to two different reagents prepared from Mycobacterium tuberculosisS M Morley, J S Beck, J M Grange, et al.
Gene Therapy|June 25, 2004
Functional improvement of mutant keratin cells on addition of desmin: an alternative approach to gene therapy for dominant diseasesM D'Alessandro, S M Morley, P H Ogden, et al.
The British Journal of Dermatology|June 14, 2005
A new, recurrent mutation of GJB3 (Cx31) in erythrokeratodermia variabilisS M Morley, M I White, M Rogers, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
QJM : Monthly Journal of the Association of Physicians|July 1, 1997
Keratin and the skin: past, present and futureS M Morley
Hospital Medicine (London, England : 1998)|November 25, 2000
Hydroxyurea-induced leg ulcersJ Murphy, S M Morley
Clinical and Experimental Dermatology|January 1, 1985
Epidermal thickness in systemic sclerosis and morphoeaS M Morley, P M Gaylarde, I Sarkany
Journal of the European Academy of Dermatology and Venereology : JEADV|May 11, 2006
Calciphylaxis--a topical overviewG Arseculeratne, A T Evans, S M Morley
The Journal of Pathology|July 1, 1983
Membrane-bound structures at the interface between tumour and dermis in basal cell carcinoma. An ultrastructural studyS M Morley, A Rennison, R F Macadam
Journal of Clinical Pathology|August 1, 1987
Unresponsiveness to skin testing with bacterial antigens in patients with haemophilia A not apparently infected with human immunodeficiency virus (HIV)R A Sharp, S M Morley, J S Beck, et al.
Tubercle|March 1, 1987
Occupational exposure to Mycobacterium tuberculosis and cytology of response to skin testing with 'New Tuberculin'S M Morley, J S Beck, R A Brown, et al.
Clinical and Experimental Immunology|September 1, 1987
The method of preparation of an antigen may influence the cellular reaction to it in skin tests for delayed hypersensitivity: comparison between responses to two different reagents prepared from Mycobacterium tuberculosisS M Morley, J S Beck, J M Grange, et al.
Gene Therapy|June 25, 2004
Functional improvement of mutant keratin cells on addition of desmin: an alternative approach to gene therapy for dominant diseasesM D'Alessandro, S M Morley, P H Ogden, et al.
The British Journal of Dermatology|June 14, 2005
A new, recurrent mutation of GJB3 (Cx31) in erythrokeratodermia variabilisS M Morley, M I White, M Rogers, et al.
Pageof 3